Canterbury DHB



ET is a chronic, slowly progressive disease, and thus any intervention needs to carry minimum risk to the patient. The following table reflects this conservative approach.

See Campbell PJ, Green AR (2005),3 table 4 for recommendations for management of patients with ET.

For current trials in ET, check the Clintrial NZ app or phone the Clinical Trials Co-ordinator (ext: 80377).

About this Canterbury DHB document (6238):

Document Owner:

Bridgett McDiarmid (see Who's Who)

Last Reviewed:

August 2018

Next Review:

April 2021


Note: Only the electronic version is controlled. Once printed, this is no longer a controlled document. Disclaimer

Topic Code: 6238